BEAM
Price
$17.25
Change
+$1.02 (+6.28%)
Updated
May 8 closing price
Capitalization
1.63B
95 days until earnings call
RCKT
Price
$7.04
Change
+$0.73 (+11.57%)
Updated
May 8 closing price
Capitalization
715.46M
94 days until earnings call
Ad is loading...

BEAM vs RCKT

Header iconBEAM vs RCKT Comparison
Open Charts BEAM vs RCKTBanner chart's image
Beam Therapeutics
Price$17.25
Change+$1.02 (+6.28%)
Volume$3.15M
Capitalization1.63B
Rocket Pharmaceuticals
Price$7.04
Change+$0.73 (+11.57%)
Volume$2.68M
Capitalization715.46M
BEAM vs RCKT Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. RCKT commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and RCKT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (BEAM: $17.25 vs. RCKT: $7.04)
Brand notoriety: BEAM and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 119% vs. RCKT: 93%
Market capitalization -- BEAM: $1.63B vs. RCKT: $715.46M
BEAM [@Biotechnology] is valued at $1.63B. RCKT’s [@Biotechnology] market capitalization is $715.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while RCKT’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • RCKT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BEAM and RCKT are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -13.01% price change this week, while RCKT (@Biotechnology) price change was -10.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +15.24%, and the average quarterly price growth was -12.41%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

RCKT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.63B) has a higher market cap than RCKT($715M). BEAM YTD gains are higher at: -30.444 vs. RCKT (-43.994). RCKT has higher annual earnings (EBITDA): -247.48M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. RCKT (372M). RCKT has less debt than BEAM: RCKT (25.5M) vs BEAM (161M). BEAM has higher revenues than RCKT: BEAM (63.5M) vs RCKT (0).
BEAMRCKTBEAM / RCKT
Capitalization1.63B715M228%
EBITDA-383.98M-247.48M155%
Gain YTD-30.444-43.99469%
P/E RatioN/AN/A-
Revenue63.5M0-
Total Cash851M372M229%
Total Debt161M25.5M631%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMRCKT
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVOIX17.720.15
+0.85%
Macquarie Mid Cap Income Opps I
JORCX17.020.06
+0.35%
Janus Henderson Global Select C
AULRX73.52N/A
N/A
American Century Ultra® R
MOJCX13.02N/A
N/A
Donoghue Forlines Momentum C
JERNX11.69-0.09
-0.76%
Janus Henderson Global Real Estate N